Sage Journals: Discover world-class research

Open access

Review article

First published 2019

Platelet Apoptosis Can Be Triggered Bypassing the Death Receptors

Valery Leytin, Armen V. Gyulkhandanyan, John Freedman

Clinical and Applied Thrombosis/Hemostasis

Free access

Review article

First published 2015-1

Anti-programmed death receptor 1 immunotherapy in melanoma: rationale,evidence and clinical potential

Morganna Freeman-Keller, Jeffrey S. Weber

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023-1

Indirubin Inhibits TRAIL-Induced Activation of Death Receptor 5 in Jurkat Cells

Malaney C. Young, Nagamani Vunnam, Robyn T. Rebbeck [...]

Natural Product Communications

Open access

Review article

First published 2022-06

Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody

Lin Zhang, Zhihua Geng, Bo Hao [...]

Cancer Control

Free access

Research article

First published 2021-12

DR4-Associated Death Receptor Signal Promotes Cartilage Damage in Patients With Kashin-Beck Disease

Shixun Wu, Zhi Yi, Ming Ling [...]

CARTILAGE

Retricted access

Research article

First published 1998-07

Review: Death Domain Receptors and Their Role in Cell Demise

Arjun Singh, Jian NI, Bharat B. Aggarwal

Journal of Interferon & Cytokine Research

Open access

Research article

First published 2017-8

Nicotinic Receptor Abnormalities in the Cerebellar Cortex of Sudden Unexplained Fetal and Infant Death Victims—Possible Correlation With Maternal Smoking

Anna M. Lavezzi, Stefano Ferrero, Luca Roncati [...]

ASN Neuro

Retricted access

Research article

First published 2001-10

Thyrocyte Targets and Effectors of Autoimmunity: A Role for Death Receptors?

Linda J. Hammond, F. Fausto Palazzo, Marion Shattock [...]

Thyroid®

Retricted access

Research article

First published 2012-11

Bax is Essential for Death Receptor-Mediated Apoptosis in Human Colon Cancer Cells

Shunqin Zhu, Tai Li, Juan Tan [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Case report

First published 2020-6

Behcet’s-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy

Steffi Thomas, Chay Bae, Tabanor Joy-Ann [...]

Journal of Oncology Pharmacy Practice

Search results